Two New Federal Efforts Designed to Accelerate Clinical Trials.

Published in

Cancer discovery. Pages OF1. Oct 14, 2026. Epub Oct 14, 2026.

Abstract

Both ARPA-H and the FDA recently launched programs to help accelerate clinical trials. ARPA-H announced the SURPASS program, which is intended to create faster clinical trials that are more cost-effective and have fewer participants than current studies. It is seeking ideas from cross-disciplinary teams in statistics, artificial intelligence, and clinical trial design, operations, and regulation. The FDA has created a pilot program for accelerating phase I clinical trials that pairs drug sponsors with research organizations.

PMID:
42873734
Bibliographic data and abstract were imported from PubMed on 15 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.